000 01486 a2200481 4500
005 20250517001836.0
264 0 _c20150508
008 201505s 0 0 eng d
022 _a1476-5551
024 7 _a10.1038/leu.2014.313
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWaxman, A J
245 0 0 _aClassifying ultra-high risk smoldering myeloma.
_h[electronic resource]
260 _bLeukemia
_cMar 2015
300 _a751-3 p.
_bdigital
500 _aPublication Type: Letter; Research Support, N.I.H., Extramural
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Light Chains
_xblood
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Statistical
650 0 4 _aMonoclonal Gammopathy of Undetermined Significance
_xblood
650 0 4 _aMultiple Myeloma
_xblood
650 0 4 _aNeoplasms, Plasma Cell
_xblood
650 0 4 _aPatient Selection
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
650 0 4 _aSerum Albumin
_xmetabolism
700 1 _aMick, R
700 1 _aGarfall, A L
700 1 _aCohen, A
700 1 _aVogl, D T
700 1 _aStadtmauer, E A
700 1 _aWeiss, B M
773 0 _tLeukemia
_gvol. 29
_gno. 3
_gp. 751-3
856 4 0 _uhttps://doi.org/10.1038/leu.2014.313
_zAvailable from publisher's website
999 _c24329951
_d24329951